Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update
Authors
Keywords
-
Journal
SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE
Volume 21, Issue 1, Pages -
Publisher
AOSIS
Online
2020-09-17
DOI
10.4102/sajhivmed.v21i1.1115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ‘Covering the tail’ after stopping efavirenz-based antiretroviral therapy
- (2020) Gary Maartens SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE
- Emtricitabine-associated red cell aplasia
- (2019) Karen Cohen et al. AIDS
- A lower dose of efavirenz can be co-administered with rifampicin and isoniazid in tuberculosis patients
- (2019) Julian P Kaboggoza et al. Open Forum Infectious Diseases
- Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial
- (2019) Michael Aboud et al. LANCET INFECTIOUS DISEASES
- ART reduces T cell activation and immune exhaustion markers in HIV controllers
- (2019) Jonathan Z Li et al. CLINICAL INFECTIOUS DISEASES
- Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-week Results of AIDS Clinical Trials Group A5241 (OPTIONS)
- (2019) Rajesh T Gandhi et al. JOURNAL OF INFECTIOUS DISEASES
- Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
- (2019) Alison J Rodger et al. LANCET
- A systematic review of the genetic mechanisms of dolutegravir resistance
- (2019) Soo-Yon Rhee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana
- (2019) Rebecca Zash et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV
- (2019) Willem D.F. Venter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dolutegravir Use at Conception — Additional Surveillance Data from Botswana
- (2019) Mmakgomo M. Raesima et al. NEW ENGLAND JOURNAL OF MEDICINE
- Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study
- (2019) Beatriz Grinsztejn et al. Lancet HIV
- Management of active tuberculosis in adults with HIV
- (2019) Graeme Meintjes et al. Lancet HIV
- Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial
- (2019) Willem D F Venter et al. Lancet HIV
- Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women
- (2019) Amita Gupta et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics of Efavirenz 400 mg Once Daily During Pregnancy and Post-Partum
- (2018) Mohammed Lamorde et al. CLINICAL INFECTIOUS DISEASES
- Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight)
- (2018) Jean-Michel Molina et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies
- (2018) Josep M Llibre et al. LANCET
- The unexpected success of NRTIs in second-line treatment
- (2018) Andrew M Hill et al. LANCET INFECTIOUS DISEASES
- Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study
- (2018) Lucas E Hermans et al. LANCET INFECTIOUS DISEASES
- HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis
- (2018) Ravindra K Gupta et al. LANCET INFECTIOUS DISEASES
- An overview of tenofovir and renal disease for the HIV-treating clinician
- (2018) Willem D.F. Venter et al. SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE
- Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study
- (2018) Benjamin R Bavinton et al. Lancet HIV
- A clinical prediction rule for protease inhibitor resistance in patients failing second-line antiretroviral therapy
- (2018) Karen Cohen et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Third-Line Antiretroviral Therapy Program in the South African Public Sector
- (2018) Michelle Moorhouse et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
- (2018) Pedro Cahn et al. LANCET
- Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS
- (2018) Graeme Meintjes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Brief Report
- (2017) Ebrahim Variava et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting
- (2017) Christopher D. Pilcher et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study
- (2017) Catherine Orrell et al. Lancet HIV
- Consensus statement: Management of drug-induced liver injury in HIV-positive patients treated for TB
- (2017) E Jong et al. SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE
- Identification of a novel and severe pattern of efavirenz drug-induced liver injury in South Africa
- (2016) Mark W. Sonderup et al. AIDS
- Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
- (2016) Alison J. Rodger et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Population pharmacokinetic drug–drug interaction pooled analysis of existing data for rifabutin and HIV PIs
- (2016) Stefanie Hennig et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antiretroviral Therapy for the Prevention of HIV-1 Transmission
- (2016) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Initiating Antiretroviral Therapy for HIV at a Patient’s First Clinic Visit: The RapIT Randomized Controlled Trial
- (2016) Sydney Rosen et al. PLOS MEDICINE
- Cases of antiretroviral-associated gynaecomastia reported to the National HIV & Tuberculosis Health Care Worker Hotline in South Africa
- (2016) Christine Njuguna et al. AIDS Research and Therapy
- Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study
- (2016) Alberto M La Rosa et al. Lancet HIV
- Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial
- (2016) Gideon Amanyire et al. Lancet HIV
- Therapy-Emergent Drug Resistance to Integrase Strand Transfer Inhibitors in HIV-1 Patients: A Subgroup Meta-Analysis of Clinical Trials
- (2016) Jiangzhou You et al. PLoS One
- Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis
- (2015) Olalekan A. Uthman et al. ANNALS OF INTERNAL MEDICINE
- Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa
- (2015) Phumla Z. Sinxadi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study
- (2015) LANCET INFECTIOUS DISEASES
- Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Third-line antiretroviral therapy in Africa: effectiveness in a Southern African retrospective cohort study
- (2015) Graeme Meintjes et al. AIDS Research and Therapy
- Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis
- (2015) Mark A Boyd et al. Lancet HIV
- Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study
- (2015) Jean-Michel Molina et al. Lancet HIV
- Social and ethical implications of HIV cure research
- (2014) Joseph D. Tucker et al. AIDS
- Rilpivirine Versus Efavirenz with Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naïve HIV-1–Infected Patients with HIV-1 RNA ≤100,000 Copies/mL: Week 96 Pooled ECHO/THRIVE Subanalysis
- (2014) Georg Behrens et al. AIDS PATIENT CARE AND STDS
- Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America
- (2014) Gregory M. Lucas et al. CLINICAL INFECTIOUS DISEASES
- Virological efficacy of abacavir: systematic review and meta-analysis
- (2014) M. Cruciani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection
- (2014) Trevor A. Crowell et al. JOURNAL OF INFECTIOUS DISEASES
- Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial
- (2014) Molebogeng X Rangaka et al. LANCET
- Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa
- (2014) Nicholas I. Paton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis
- (2014) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Virologic Failure Following Persistent Low-level Viremia in a Cohort of HIV-Positive Patients: Results From 12 Years of Observation
- (2013) C. Laprise et al. CLINICAL INFECTIOUS DISEASES
- Evidence for Innate Immune System Activation in HIV Type 1–Infected Elite Controllers
- (2013) Sonya Krishnan et al. JOURNAL OF INFECTIOUS DISEASES
- Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
- (2013) Pedro Cahn et al. LANCET
- Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial
- (2013) François Raffi et al. LANCET INFECTIOUS DISEASES
- Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
- (2013) Sharon L. Walmsley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies
- (2013) Leigh F. Johnson et al. PLOS MEDICINE
- Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials
- (2012) Calvin J. Cohen et al. AIDS
- The Safety, Effectiveness and Concentrations of Adjusted Lopinavir/Ritonavir in HIV-Infected Adults on Rifampicin-Based Antitubercular Therapy
- (2012) Eric H. Decloedt et al. PLoS One
- Should We Treat Acute HIV Infection?
- (2012) Meagan O’Brien et al. Current HIV/AIDS Reports
- Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients
- (2011) Pedro Cahn et al. AIDS
- No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Term Results from ACTG A5001/ALLRT
- (2011) H. J. Ribaudo et al. CLINICAL INFECTIOUS DISEASES
- Timing of Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus (HIV)-Associated Tuberculous Meningitis
- (2011) M. E. Torok et al. CLINICAL INFECTIOUS DISEASES
- Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Data Meta-analysis of Observational Studies
- (2011) Haileyesus Getahun et al. PLOS MEDICINE
- Efavirenz directly modulates the oestrogen receptor and induces breast cancer cell growth
- (2010) MJ Sikora et al. HIV MEDICINE
- Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1-Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study
- (2010) Jean-Michel Molina et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A CD4+ Cell Count
- (2010) Mona R Loutfy et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions
- (2010) Lewis J Haddow et al. LANCET INFECTIOUS DISEASES
- Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis
- (2009) Anthony M Mills et al. AIDS
- High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment‐Experienced Patients Infected with Multidrug‐Resistant HIV: Results of the ANRS 139 TRIO Trial
- (2009) Y. Yazdanpanah et al. CLINICAL INFECTIOUS DISEASES
- Will Etravirine Work in Patients Failing Nonnucleoside Reverse Transcriptase Inhibitor-Based Treatment in Southern Africa?
- (2009) Wendy S Stevens et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Mortality Associated With Discordant Responses to Antiretroviral Therapy in Resource-Constrained Settings
- (2009) Suely Hiromi Tuboi et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial
- (2009) Andrew R. Zolopa et al. PLoS One
- Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings
- (2008) Graeme Meintjes et al. LANCET INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started